Detecting Acute Lymphoblastic Leukemia in down Syndrome Patients Using Convolutional Neural Networks on Preprocessed Mutated Datasets

Author(s):  
Maram Shouman ◽  
Nahla Belal ◽  
Yasser El Sonbaty
2021 ◽  
pp. 100794
Author(s):  
Chayan Mondal ◽  
Md. Kamrul Hasan ◽  
Mohiuddin Ahmad ◽  
Md. Abdul Awal ◽  
Md. Tasnim Jawad ◽  
...  

Author(s):  
Chayan Mondal ◽  
Md. Kamrul Hasan ◽  
Md. Tasnim Jawad ◽  
Aishwariya Dutta ◽  
Md. Rabiul Islam ◽  
...  

Although automated Acute Lymphoblastic Leukemia (ALL) detection is essential, it is challenging due to the morphological correlation between malignant and normal cells. The traditional ALL classification strategy is arduous, time-consuming, often suffers inter-observer variations, and necessitates experienced pathologists. This article has automated the ALL detection task, employing deep Convolutional Neural Networks (CNNs). We explore the weighted ensemble of deep CNNs to recommend a better ALL cell classifier. The weights are estimated from ensemble candidates' corresponding metrics, such as accuracy, F1-score, AUC, and kappa values. Various data augmentations and pre-processing are incorporated for achieving a better generalization of the network. We train and evaluate the proposed model utilizing the publicly available C-NMC-2019 ALL dataset. Our proposed weighted ensemble model has outputted a weighted F1-score of 88.6%, a balanced accuracy of 86.2%, and an AUC of 0.941 in the preliminary test set. The qualitative results displaying the gradient class activation maps confirm that the introduced model has a concentrated learned region. In contrast, the ensemble candidate models, such as Xception, VGG-16, DenseNet-121, MobileNet, and InceptionResNet-V2, separately produce coarse and scatter learned areas for most example cases. Since the proposed ensemble yields a better result for the aimed task, it can experiment in other domains of medical diagnostic applications.


2019 ◽  
Vol 18 ◽  
pp. 153473541983235
Author(s):  
Linda Bühl ◽  
Thomas Abel ◽  
Florian Wolf ◽  
Max Oberste ◽  
Wilhelm Bloch ◽  
...  

In patients with hematological malignancies, exercise is studied as a supportive measure with potential benefits on therapy and disease-related side effects. However, clinical trials have not yet integrated people with Down syndrome (DS), although this disability is associated with an increased risk for hematological malignancies. Therefore, we examined safety and feasibility of a mixed-modality exercise intervention in a male with DS undergoing high-dose chemotherapy for acute lymphoblastic leukemia. Furthermore, physical capacity and fatigue were assessed. Exercise sessions took place 3 times/wk over a 5-week period. Adherence to the exercise program was 100%, and no serious adverse events occurred. In contrast to the training sessions, applied endurance testing was not feasible. Furthermore, maintenance of fatigue level was observed. In conclusion, cancer patients with DS suffering from leukemia should not be excluded from physical activity or exercise programs.


2019 ◽  
Vol 66 (5) ◽  
pp. e27612 ◽  
Author(s):  
Shinsuke Hirabayashi ◽  
Daisuke Hasegawa ◽  
Kaoru Yamamoto ◽  
Akira Nishimura ◽  
Yosuke Hosoya ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document